RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
DENARO N
Collezione AO Cuneo
Items : 48
Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma. in Oral oncology / Oral Oncol. 2023 Oct;145:106540. doi: 10.1016/j.oraloncology.2023.106540. Epub 2023 Aug 9.
2023
AO Cuneo
Roberti E; Merlano M; Ravanelli M; Alberti A; Esposito A; Gili R; Spinazzé S; Baré C; Jocollé G; Benasso M; Bertolotti F; Vecchio S; Bacigalupo A; Licitra L; Denaro N; Damico M; Lorini L; Gurizzan C; Alfieri S; Bossi P;
Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib. in Vaccines / Vaccines (Basel). 2023 Feb 2;11(2):335. doi: 10.3390/vaccines11020335.
2023
AO Cuneo
Abbona A; Ricci V; Paccagnella M; Granetto C; Ruatta F; Cauchi C; Galizia D; Ghidini M; Denaro N; Merlano MC; Garrone O;
Why Oncologists Should Feel Directly Involved in Persuading Patients with Head and Neck Cancer to Quit Smoking. in Oncology / Oncology. 2023;101(4):252-256. doi: 10.1159/000528345. Epub 2022 Dec 20.
2023
AO Cuneo
Bossi P; Garrone O; Galizia D; Abbona A; Paccagnella M; Minei S; Merlano MC; Denaro N;
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer. in Cells / Cells. 2022 Oct 10;11(19):3176. doi: 10.3390/cells11193176.
2022
AO Cuneo
AOU Novara
De Cecco L; Licitra L; Bossi P; Ferraù F; Rinaldi G; Vaccher E; Moretti G; Denaro N; Caponigro F; Rocca MC; Secondino S; Moro C; Sponghini A; Caldara A; Ferrari D; Vecchio S; Lenoci D; Pistore F; Miceli R; Canevari S; Cavalieri S; Carenzo A; Serafini MS;
Effect of Eribulin on Angiogenesis and the Expression of Endothelial Adhesion Molecules. in Anticancer research / Anticancer Res. 2022 Jun;42(6):2859-2867. doi: 10.21873/anticanres.15767.
2022
AO Cuneo
Abbona A; Paccagnella M; Astigiano S; Martini S; Denaro N; Ruatta F; Barbieri O; Merlano M; Garrone O;
Development of a prognostic model of overall survival in oropharyngeal cancer from real-world data: PRO.M.E.THE.O. in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale / Acta Otorhinolaryngol Ital. 2022 Jun;42(3):205-214. doi: 10.14639/0392-100X-N1672. Epub 2022 Apr 8.
2022
AO Cuneo
Miccichè F; Chiloiro G; Longo S; Autorino R; Massaccesi M; Lenkowicz J; Bonomo P; Desideri I; Belgioia L; Bacigalupo A; D'Angelo E; Bertolini F; Merlotti A; Denaro N; Franco P; Bussu F; Paludetti G; Ricardi U; Valentini V;
How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review. in Biomedicines / Biomedicines. 2022 Jul 28;10(8):1822. doi: 10.3390/biomedicines10081822.
2022
AO Cuneo
Garrone O; Ghidini M; Paccagnella M; Abbona A; Minei S; Denaro N; Galizia D; Ruatta F; Occelli M; Merlano MC;
Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression. in Vaccines / Vaccines (Basel). 2022 Jan 5;10(1):78. doi: 10.3390/vaccines10010078.
2022
AO Cuneo
Paccagnella M; Abbona A; Michelotti A; Geuna E; Ruatta F; Landucci E; Denaro N; Vanella P; Lo Nigro C; Galizia D; Merlano M; Garrone O;
In reply to immune desert in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment. in Oral oncology / Oral Oncol. 2022 Jan;124:105640. doi: 10.1016/j.oraloncology.2021.105640. Epub 2021 Nov 26.
2022
AO Cuneo
Denaro N; Merlano M; Garrone O;
Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy. in Vaccines / Vaccines (Basel). 2021 Mar 8;9(3):235. doi: 10.3390/vaccines9030235.
2021
AO Cuneo
Basiricò M; Gammaitoni L; Galizia D; Crosetto N; Bertetto O; Merlotti A; Ruatta F; Denaro N; Fea E; Ricci V; Granetto C; Falletta A; Paccagnella M; Abbona A; Merlano MC; Sangiolo D; Aglietta M; Garrone O;
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO). in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jun;162:103345. doi: 10.1016/j.critrevonc.2021.103345. Epub 2021 Apr 29
2021
AO Cuneo
Arcangeli S; Magrini SM; D' Angelillo RM; Bossi P; Pappagallo GL; Merlotti A; Corvò R; Paiar F; Denaro N; Maddalo M; Bonomo P; Alterio D; De Felice F; Belgioia L;
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions. in Cells / Cells. 2021 Dec 23;11(1):32. doi: 10.3390/cells11010032.
2021
AO Cuneo
Economopoulou P; Pantazopoulos A; Spathis A; Kotsantis I; Kyriazoglou A; Kavourakis G; Zakopoulou R; Chatzidakis I; Anastasiou M; Prevezanou M; Resteghini C; Licitra L; Bergamini C; Colombo E; Caspani F; Denaro N; Vecchio S; Bonomo P; Cossu Rocca M; Bertolini F; Ferrari D; Psyrri A; Bossi P;
Complete response to immunotherapy in sinonasal undifferentiated carcinoma. in Tumori / Tumori. 2021 Dec;107(6):NP101-NP104. doi: 10.1177/03008916211026971. Epub 2021 Jul 6.
2021
AO Cuneo
Denaro N; Merlano M; Numico G; Garrone O; Bossi P;
Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review. in European journal of case reports in internal medicine / Eur J Case Rep Intern Med. 2021 Jun 17;8(7):002639. doi: 10.12890/2021_002639. eCollection 2021.
2021
AO Cuneo
Denaro N; Garrone O; Occelli M; Fea E; Granetto C; Merlano MC; Numico G;
Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis. in Cancer management and research / Cancer Manag Res. 2021 May 17;13:3973-3980. doi: 10.2147/CMAR.S277907. eCollection 2021.
2021
AO Cuneo
Denaro N; Merlano MC; Lo Nigro C;
Effect of moderate physical exercise on the immune system modulation in patients with breast cancer during preoperative chemotherapy: The NEO-RUNNER study in Journal of Clinical Oncology
2021
AO Cuneo
Ruatta F; Denaro N; Merlano MC; Prina AV; Rubini D; Vanella P; Paccagnella M; Croce N; Falletta A; Abbona A; Garrone O; Vandone AM;
Cytokines performance during nivolumab treatment: A subgroup analysis of NIVACTOR study in Journal of Clinical Oncology
2021
AO Cuneo
De Zarlo L; Fiorino E; Gammaitoni L; Falletta A; Abbona A; Galizia D; Denaro N; Paccagnella M; Aglietta M; Merlano MC; Licitra LF; Sangiolo D; Bossi P;
Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy. in Tumori / Tumori. 2020 Oct;106(5):427-431. doi: 10.1177/0300891620942313. Epub 2020 Jul 23.
2020
AO Cuneo
Crosetto N; Colantonio I; Di Costanzo G; Fea E; Ricci V; Cauchi C; Occelli M; Vandone AM; Granetto C; Vanella P; Ruatta F; Denaro N; Garrone O; Merlano MC;
Immune escape mechanisms in head and neck squamous cell carcinoma and implication for new immunotherapy approach. in Current opinion in oncology / Curr Opin Oncol. 2020 May;32(3):203-209. doi: 10.1097/CCO.0000000000000623.
2020
AO Cuneo
Merlano MC; Denaro N; Garrone O;
Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). in Oral oncology / Oral Oncol. 2020 Aug;107:104801. doi: 10.1016/j.oraloncology.2020.104801. Epub 2020 May 14.
2020
AO Cuneo
Russi E; Merlano MC; Merlotti AM; Denaro N;
Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC). in Oral oncology / Oral Oncol. 2020 Aug;107:104801. doi: 10.1016/j.oraloncology.2020.104801. Epub 2020 May 14.
2020
AO Cuneo
Denaro N; Merlotti AM; Merlano MC; Russi E;
Metastatic disease in head & neck oncology. in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale / Acta Otorhinolaryngol Ital. 2020 Apr;40(SUPPL. 1):S1-S86. doi: 10.14639/0392-100X-suppl.1-40-2020.
2020
ASL Asti
ASL Vercelli
ASL Torino 3
AOU Città della Salute di Torino
AO Cuneo
AOU Alessandria
AOU Novara
Zannetti M; Valente G; Serra A; Scasso F; Prioglio L; Rugiu MG; Prina-Mello A; Pisani S; Masini L; Merlano MC; Piemonte M; Maroldi R; Mancuso M; Magnano M; Lanza GV; Landolfo V; Iasi GA; Krengli M; Genta I; Garzaro M; Galizia D; Fantozzi C; Denaro N; Costanzo A; Della Vecchia L; Conti B; Colombo A; Zigliani A; Cacciola S; et alii...
Phase III Randomized Study of Induction Chemotherapy Followed by Definitive Radiotherapy + Cetuximab Versus Chemoradiotherapy in Squamous Cell Carcinoma of Head and Neck: The INTERCEPTOR-GONO Study (NCT00999700). in Oncology / Oncology. 2020;98(11):763-770. doi: 10.1159/000507733. Epub 2020 Jul 6.
2020
AO Cuneo
Merlano MC; Denaro N; Vecchio S; Licitra L; Curcio P; Benasso M; Bagicalupo A; Numico G; Russi E; Corvo' R; Bruzzi P;
Difficulties in conducting pure academic research, obstacles in data collection and quality of informations: The example of the INTERCEPTOR study. in Oral oncology / Oral Oncol. 2019 Oct;97:99-104. doi: 10.1016/j.oraloncology.2019.08.019. Epub 2019 Aug 28.
2019
AO Cuneo
Merlano M; Denaro N; Benasso M; Licitra L; Bossi P; Locati L; Vecchio S; Bruzzi P;
Unexpected response with palliative conventional therapy in head and neck squamous cell carcinoma after anti-programmed death-1 progression. in Head & neck / Head Neck. 2019 Mar;41(3):E42-E47. doi: 10.1002/hed.25418. Epub 2019 Jan 5.
2019
AO Cuneo
Merlano MC; Denaro N;
Long noncoding RNAs as regulators of cancer immunity. in Molecular oncology / Mol Oncol. 2019 Jan;13(1):61-73. doi: 10.1002/1878-0261.12413. Epub 2018 Dec 13.
2019
AO Cuneo
Denaro N; Merlano MC; Lo Nigro C;
Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer. in Dysphagia / Dysphagia. 2019 Feb;34(1):52-62. doi: 10.1007/s00455-018-9913-8. Epub 2018 Jun 8.
2019
AO Cuneo
Fallai C; Pizzorni N; Schindler A; Merlotti A; Vigna-Taglianti R; Denaro N; Cossu Rocca M; Alterio D; Mirabile A; Infante G; Miceli R; Orlandi E; Licitra L; Bossi P;
Knowing the tumour microenvironment to optimise immunotherapy. in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale / Acta Otorhinolaryngol Ital. 2019 Feb;39(1):2-8. doi: 10.14639/0392-100X-2481.
2019
AO Cuneo
Merlano MC; Abbona A; Denaro N; Garrone O;
In response to Ham et al.: Antibiotics effect on outcome in head and neck cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2019 Aug;117:119-120. doi: 10.1016/j.ejca.2019.05.021. Epub 2019 Jul 3.
2019
AO Cuneo
Denaro N; Merlano MC;
Lenvatinib Long-Term Responses in Refractory Thyroid Cancer: Our Mono-Institutional Real-Life Experience with the Multidisciplinary Approach and Review of Literature. in Oncology / Oncology. 2019;97(4):206-210. doi: 10.1159/000501691. Epub 2019 Aug 7.
2019
AO Cuneo
Merlano MC; Borretta G; Corrado L; Bramardi F; Cesario F; Latina A; Denaro N;
How I treat squamous ENT cancer. in ESMO open / ESMO Open. 2019 Jul 16;4(Suppl 2):e000542. doi: 10.1136/esmoopen-2019-000542. eCollection 2019.
2019
AO Cuneo
Merlano MC; Denaro N; Galizia D; Garrone O;
DUSP2 methylation is a candidate biomarker of outcome in head and neck cancer. in Annals of translational medicine / Ann Transl Med. 2018 Jul;6(13):271. doi: 10.21037/atm.2018.06.39.
2018
AO Cuneo
Lo Nigro C; Vivenza D; Denaro N; Lattanzio L; Fortunato M; Crook T; Merlano MC;
Immunotherapy in Head and Neck Squamous Cell Cancer. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2018 Dec;11(4):217-223. doi: 10.21053/ceo.2018.00150. Epub 2018 Jul 6.
2018
AO Cuneo
Merlano MC; Denaro N;
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide. in Clinical and translational radiation oncology / Clin Transl Radiat Oncol. 2018 Aug 13;12:47-52. doi: 10.1016/j.ctro.2018.08.001. eCollection 2018 Au
2018
AO Ordine Mauriziano
AO Cuneo
Corvò R; Russi EG; Vecchio S; Curcio P; Fruttero C; Galizia D; Di Maio M; Denaro N; Fea E; Licitra L; Merlano MC; Merlotti AM;
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Nov 1;28(11):2820-2826. doi: 10.1093/annonc/mdx439.
2017
AOU Città della Salute di Torino
AO Cuneo
AOU Novara
Licitra L; Hollander L; Tettamanzi F; Ferrau F; Nolè F; Lo Vullo S; Rinaldi G; Caldara A; Sponghini A; Vaccher E; Moro C; Airoldi M; Caponigro F; Moretti G; Denaro N; Vecchio S; Ferrari D; Locati LD; Miceli R; Bossi P;
Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2017 May;66(5):573-579. doi: 10.1007/s00262-017-1960-8. Epub 2017 Feb 14.
2017
AO Cuneo
Lattanzio L; Denaro N; Vivenza D; Varamo C; Strola G; Fortunato M; Chamorey E; Comino A; Monteverde M; Lo Nigro C; Milano G; Merlano M;
Head and neck cancer: improving outcomes with a multidisciplinary approach. in Cancer management and research / Cancer Manag Res. 2017 Aug 18;9:363-371. doi: 10.2147/CMAR.S115761. eCollection 2017.
2017
AO Cuneo
Lo Nigro C; Denaro N; Merlotti A; Merlano M;
Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2016 Dec;9(4):287-297. doi: 10.21053/ceo.2015.00976. Epub 2016 Jun 25.
2016
AO Cuneo
Denaro N; Merlano MC; Russi EG;
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Oct;96(1):167-82. doi: 10.1016/j.critrevonc.2015.06.001. Epub 2015 Jul
2015
AO Cuneo
AOU Città della Salute di Torino
Girolomoni G; Langendijk JA; Bensadoun RJ; Pinto C; Pergolizzi S; Denaro N; Licitra L; Merlano MC; Lombardo A; Airoldi M; Buglione M; Bossi P; Numico G; De Sanctis V; Bacigalupo A; Benasso M; Rampino M; Russi EG; Moretto F;
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Nov;96(2):372-84. doi: 10.1016/j.critrevonc.2015.06.005. Epub 2015 Jun
2015
AO Cuneo
Murphy B; Langendijk JA; Merlano MC; Licitra L; Ripamonti C; Pavanato G; De Sanctis V; Bacigalupo A; Alterio D; Buglione M; Caspiani O; Orlandi E; Gava A; Numico G; Spadola Bissetti M; Merlotti A; Bossi P; Pizzorni N; Russi EG; Denaro N; Schindler A; Sanguineti G;
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2015 Aug;95(2):191-213. doi: 10.1016/j.critrevonc.2015.03.003. Epub 2015 Mar
2015
AO Cuneo
AOU Città della Salute di Torino
Vermorken JB; Dellinger RP; Ranieri MV; Murphy B; Bernier J; Raber-Durlacher J; Cascio A; Pergolizzi S; Buglione M; Caspiani O; Denaro N; Moretto F; Licitra L; Merlano MC; Ghi MG; Merlotti A; Musso S; De Sanctis V; Bacigalupo A; Crippa F; Bossi P; Russi EG; Numico G; Mirabile A;
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. in Urologic oncology / Urol Oncol. 2014 Jan;32(1):30.e1-7. doi: 10.1016/j.urolonc.2012.10.011. Epub 2013 Feb 12.
2014
AO Cuneo
Ricardi U; Pergolizzi S; Buglione M; Arena G; Lucio F; Denaro N; Gianello L; Boriano A; Russi EG; Vigna-Taglianti R; Magrini S;
Non coding RNAs in head and neck squamous cell carcinoma (HNSCC): a clinical perspective. in Anticancer research / Anticancer Res. 2014 Dec;34(12):6887-96.
2014
AO Cuneo
Lo Nigro C; Russi EG; Merlano MC; Denaro N;
State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013. in Oncology / Oncology. 2014;86(4):212-29. doi: 10.1159/000357712. Epub 2014 May 10.
2014
AO Cuneo
Denaro N; Russi EG; Adamo V; Merlano MC;
Dysphagia in Head and Neck Cancer Patients: Pretreatment Evaluation, Predictive Factors, and Assessment during Radio-Chemotherapy, Recommendations. in Clinical and experimental otorhinolaryngology / Clin Exp Otorhinolaryngol. 2013 Sep;6(3):117-26. doi: 10.3342/ceo.2013.6.3.117. Epub 2013 Sep 4.
2013
AO Cuneo
Denaro N; Merlano MC; Russi EG;
The role of antiangiogenic agents in the treatment of head and neck cancer. in Oncology / Oncology. 2012;83(2):108-16. doi: 10.1159/000339542. Epub 2012 Jul 9.
2012
AO Cuneo
Denaro N; Russi EG; Colantonio I; Adamo V; Merlano MC;
Radiation-induced pemphigus vulgaris of the breast. in Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique / Cancer Radiother. 2011 Jul;15(4):334-7. doi: 10.1016/j.canrad.2011.01.006. Epub 2011 Apr 20.
2011
AO Cuneo
Vigna-Taglianti R; Russi EG; Denaro N; Numico G; Brizio R;
The Role of p53 and MDM2 in Head and Neck Cancer. in ISRN otolaryngology / ISRN Otolaryngol. 2011 Dec 7;2011:931813. doi: 10.5402/2011/931813. Print 2011.
2011
AO Cuneo
Denaro N; Lo Nigro C; Natoli G; Russi EG; Adamo V; Merlano MC;